Sugargic PM 2mg/500mg/15mg Tablet SR
Marketer
Neorangic Healthcare Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sugargic PM 2mg/500mg/15mg Tablet SR
DiaBeta-PM 2mg/500mg/15mg extended-release tablets are a combined medication formulated to manage blood glucose levels. This medication complements dietary changes and exercise to enhance glycemic control in adult patients with type 2 diabetes. It promotes efficient insulin utilization, consequently reducing blood sugar. DiaBeta-PM should be administered precisely as directed by your physician, adhering to the prescribed dosage and duration. Ingestion with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Avoid doubling the dose. Overdosage can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor about any pre-existing kidney, liver, or heart conditions. Pregnant or lactating women should consult their physician before use. Renal function tests will be conducted prior to treatment initiation. Limit alcohol consumption, as this can elevate the likelihood of adverse reactions.
Primary Ingredients of Sugargic PM 2mg/500mg/15mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Sugargic PM 2mg/500mg/15mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Sugargic PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Sugargic PM 2mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Sugargic PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sugargic PM 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sugargic PM 2mg/500mg/15mg Tablet SR whole; avoid crushing, chewing, or breaking. Administer with a meal.
How Sugargic PM 2mg/500mg/15mg Tablet SR works:
Sugargic PM 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts via multiple pathways: decreasing hepatic glucose production, impeding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugargic PM 2mg/500mg/15mg Tablet SR with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sugargic PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice from your doctor.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet Sugargic PM (2mg/500mg/15mg) is likely unsafe for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Sugargic PM 2mg/500mg/15mg SR tablets. Dosage modification may be necessary; physician consultation is advised. The use of Sugargic PM 2mg/500mg/15mg SR tablets is contraindicated in individuals with severely compromised kidney function. Close monitoring of renal parameters is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Sugargic PM 2mg/500mg/15mg Tablet SR. Dosage modifications for Sugargic PM 2mg/500mg/15mg Tablet SR may be necessary; physician consultation is advised. Sugargic PM 2mg/500mg/15mg Tablet SR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sugargic PM 2mg/500mg/15mg Tablet SR :
Should you forget a Sugargic PM 2mg/500mg/15mg Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugargic PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently